Showing results (181-190 of 249) with videos related to
Sort By:
Pageof 25
Aging|December 7, 2016
The progeroid gene BubR1 regulates axon myelination and motor functionChan-Il Choi, Ki Hyun Yoo, Syed Mohammed Qasim Hussaini, et al.JAMA Neurology|September 22, 2015
Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic DiseasesBharath Wootla, Jens O Watzlawik, Arthur E Warrington, et al.Fluids and Barriers of the CNS|December 20, 2023
Methodological and analytical considerations for intra-operative microdialysisCecile Riviere-Cazaux, Karishma Rajani, Masum Rahman, et al.The Journal of Biological Chemistry|November 8, 2015
Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple SclerosisLaila M Poisson, Hamid Suhail, Jaspreet Singh, et al.Neurology|October 19, 2018
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the USKristen M Krysko, Jennifer Graves, Mary Rensel, et al.Neurology|December 20, 2015
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers reportTanuja Chitnis, Jayne Ness, Lauren Krupp, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 28, 2012
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosisMelih Tutuncu, Junger Tang, Nuhad Abou Zeid, et al.Pediatrics|July 1, 2016
Characteristics of Children and Adolescents With Multiple SclerosisAnita L Belman, Lauren B Krupp, Cody S Olsen, et al.Neurology|November 16, 2014
Relapses and disability accumulation in progressive multiple sclerosisM Mateo Paz Soldán, Martina Novotna, Nuhad Abou Zeid, et al.Multiple Sclerosis and Related Disorders|March 15, 2025
Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated diseaseRebecca MacRae, Jonathan Race, Allison Schuette, et al.Pageof 25